Drug Information

Product NDC: 71500-110

Proprietary Name: LAZANDA

Non Proprietary Name: fentanyl

Active Ingredient(s):

Administration Route(s): NASAL

Dosage Form(s): SPRAY

Pharmacy Class(es):
  • Full Opioid Agonists [MoA];
  • Opioid Agonist [EPC]

Labeler Information

Labeler Name: West Therapeutic Development LLC
FDA Application Number: NDA022569
Marketing Category: NDA
Start Marketing Date:8/25/2018
DEA Schedule:CII

Package Information

No. Package Code Package Description Billing Unit
171500-110-011 BOTTLE, SPRAY in 1 CARTON (71500-110-01) > 8 SPRAY in 1 BOTTLE, SPRAYEA

NDC Record

Field Name Field Value Definition
PRODUCT NDC71500-110The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMELAZANDAThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEfentanylThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESPRAYThe translation of the dosage form Code submitted by the firm.
ROUTE NAMENASALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE8/25/2018This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMENDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERNDA022569This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEWest Therapeutic Development LLCName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEFENTANYL CITRATEThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
PHARM CLASSESFull Opioid Agonists [MoA],Opioid Agonist [EPC] 
DEA SCHEDULECIIThis is the assigned DEA Schedule number as reported by the labeler. Values are CI, CII, CIII, CIV, and CV.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 7/3/2020